Students Research in Progress
Monday, November 13, 2023
01:00 PM–02:30 PM
Abstract
Introduction:
Disparities in the diagnosis and management of infectious diseases in the US healthcare system have been reported; however, research on racial differences in pyelonephritis clinical outcomes is limited. Individuals from racially and ethnically minotirized (REM) backgrounds residing in socially vulnerable areas appear more susceptible to pyelonephritis, necessitating a thorough investigation of nuanced care outcomes. This study aims to identify disparities in clinical attributes and treatment of outpatient pyelonephritis in REM and non-REM patients in an area of varying social vulnerability.
Research Question or Hypothesis:
This study examines the existence of racial and/or social vulnerability disparities in the clinical course and outpatient management of pyelonephritis.
Study Design:
Retrospective, Chart Review
Methods:
We conducted a retrospecive chart review approved by the Institutional Review Board. The analysis will include 300 patients between 1/1/2021 and 3/1/2021 at Loma Linda University Health System. Inclusion criteria will be patients between 18 and 99 years old, ICD10 diagnosis for pyelonephritis at the time of ED or Urgent Care visit, and a urine culture collected in the ED or Urgent Care. Patients will be excluded if they were < 18 years old, or required hospitalization. . A waiver of informed consent will be submitted. Patients will be dichotomized by self-reported racial and ethnic group to identify their social vulnerability which is defined by the CDC social vulnerability calculator which analyzes the potential effects that external stresses cause in human health. Data to be collected includes documented comorbidities, social vulnerability, possible risk factors (as defined by previously published data), microbiology results, and antimicrobial treatment and stored according to protocol. Continuous and categorical variables will be reported as mean/median and proportions, respectively.
Results:
N/A
Conclusion:
N/A
Presenting Author
Sasha Rodriguez Bachelor's of Science in Biology
Loma Linda UniversityAuthors
Jacinda Abdul-Mutakabbir PharmD, MPH, AAHIVP
Skaggs School of Pharmacy and Pharmaceutical Sciences
Hadeel Al-Fayiz Bachelor's of Science in Biochemistry
Loma Linda University
Caleb McLeod PharmD
Loma Linda University Medical Center
Reem Haana Al-Kass Bachelor's of Science in Biology
Loma Linda University School of Pharmacy
Karen Tan PharmD, BCIDP
Loma Linda University Medical Center